Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
929 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Health Sciences North
Greater Sudbury, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Lakeridge Health Oshawa
Oshawa, Ontario, Canada
- Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, Canada
- Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Saint Michael'S Hospital
Toronto, Ontario, Canada
- Pei Cancer Treatment Centre-Queen Elizabeth Hospital
Charlottetown, Prince Edward Island, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
- Andres Grillasca Hospital
Ponce, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Community Oncology Group
San Juan, Puerto Rico
- San Juan Veterans Affairs Medical Center
San Juan, Puerto Rico
- University of Pretoria
Pretoria, South Africa
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Clearview Cancer Institute
Huntsville, Alabama, United States
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Providence Hospital
Mobile, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Nea Baptist Memorial Hospital
Jonesboro, Arkansas, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- John Muir Medical Center-Concord
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Washington Hospital
Fremont, California, United States
- Saint Jude Medical Center
Fullerton, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Sept 2005
- Primary completion
- 22 Feb 2024
- Completion
- 11 Apr 2027
- Last update posted
- 29 May 2026
- Registered enrollment
- 2,431
- Registry id
- NCT00217737
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.